Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Syndromic disease · Toxic or drug-related embryofetopathy
Fetal valproate syndrome
Fetal valproate syndrome (FVS), is an anticonvulsant drug-related embryofetopathy that can occur when a fetus is exposed to valproic acid (VPA), characterized by distinct facial dysmorphism, congenital anomalies and developmental delay (especially in language and communication).
This condition has no sub-types.